Naloxone duration of action is typically described as which of the following?

Naloxone duration of action is typically described as which of the following?

• A. 30 minutes
• B. 2-3 hours
• C. 6-8 hours
• D. 15-20 minutes

Answer: (A)

Naloxone has a rapid onset but a relatively short duration of action. It quickly competes at mu opioid receptors to displace opioids and reverse their effects, but because its own half-life is short (about an hour or so), the blockade can wear off while the opioid’s effects are still present. That’s why the typical duration of action described for naloxone is around 30 minutes—long enough to reverse dangerous respiratory depression acutely, but short enough that symptoms can recur if the opioid is long-acting or given in a high dose. In practice, clinicians monitor closely and may repeat dosing or use an infusion if the opioid effect persists. The other timeframes are less accurate: a longer duration would risk a longer blockade than needed and potential re-sedation once the antagonist wears off; a much shorter duration wouldn’t align with the need to observe improvement and the possibility of recurrent opioid effects.

Naloxone has a rapid onset but a relatively short duration of action. It quickly competes at mu opioid receptors to displace opioids and reverse their effects, but because its own half-life is short (about an hour or so), the blockade can wear off while the opioid’s effects are still present. That’s why the typical duration of action described for naloxone is around 30 minutes—long enough to reverse dangerous respiratory depression acutely, but short enough that symptoms can recur if the opioid is long-acting or given in a high dose. In practice, clinicians monitor closely and may repeat dosing or use an infusion if the opioid effect persists.

The other timeframes are less accurate: a longer duration would risk a longer blockade than needed and potential re-sedation once the antagonist wears off; a much shorter duration wouldn’t align with the need to observe improvement and the possibility of recurrent opioid effects.